OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Clinical Pharmacology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives	159
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study	77
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?	65
Oral Melatonin for Pain Relief During Venepuncture in Neonates– a Pilot Randomized Control Trial	48
How to make the best of NLRP3 inhibitors in patients with COVID-19?	41
Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis	38
Correction to: A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals	36
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress	36
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease	33
Identification of novel signal of DRESS associated with antibiotics: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database	32
Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation	31
Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study	30
Population pharmacokinetics and pharmacodynamics of meropenem in critically ill patients with renal impairment or on continuous renal replacement therapy	29
A systematic literature review of economic evaluations of setmelanotide	29
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study	28
Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis	27
Beyond safety: adverse events and unanticipated advantages of SGLT2 inhibitors	27
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials	26
The Effect of the combination therapy of statin and dapagliflozin, a selective inhibitor of sodium_glucose Co-transporter type 2, in the treatment of Ischemic heart disease with heart failure: A rando	26
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis	25
Comment on “Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank”	22
Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden	22
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers	22